Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             45 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 A common language in neoadjuvant breast cancer clinical trials: proposals for standard definitions and endpoints Fumagalli, Debora
2012
13 6 p. e240-e248
nvt p.
artikel
2 Addiction Incorporated Burki, Talha Khan
2012
13 6 p. 577-
1 p.
artikel
3 Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial Burmeister, Bryan H
2012
13 6 p. 589-597
9 p.
artikel
4 A new drug for Hodgkin's lymphoma Sharma, Sharan Prakash
2012
13 6 p. e236-
1 p.
artikel
5 Avoiding stem cells could spare salivary gland function Senior, Kathryn
2012
13 6 p. e239-
1 p.
artikel
6 Be clear on good health Jouret, Jill
2012
13 6 p. 575-
1 p.
artikel
7 Brachytherapy versus total breast radiation Brower, Vicki
2012
13 6 p. e236-
1 p.
artikel
8 BRCA1 mutations increase risk of prostate cancer Bennet, Neil
2012
13 6 p. e233-
1 p.
artikel
9 Canadian cuts overshadow good news on cancer statistics Senior, Kathryn
2012
13 6 p. 572-
1 p.
artikel
10 Cancer detection and primary care…revisited The Lancet Oncology,
2012
13 6 p. 559-
1 p.
artikel
11 Cancer incidence in patients with polyglutamine diseases: a population-based study in Sweden Ji, Jianguang
2012
13 6 p. 642-648
7 p.
artikel
12 Capecitabine in the treatment of rectal cancer Beets, Geerard L
2012
13 6 p. 560-561
2 p.
artikel
13 Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial Hofheinz, Ralf-Dieter
2012
13 6 p. 579-588
10 p.
artikel
14 Chinese miners at increased risk of cancer Burki, Talha Khan
2012
13 6 p. e232-
1 p.
artikel
15 Correction to Lancet Oncol 2012; 13: 569 2012
13 6 p. e231-
1 p.
artikel
16 Cut Poison Burn Yaqub, Farhat
2012
13 6 p. 578-
1 p.
artikel
17 3D histopathology could help cancer research and treatment Bennet, Neil
2012
13 6 p. e234-
1 p.
artikel
18 Exploring the limits in low rectal cancer Moran, Brendan
2012
13 6 p. 565-567
3 p.
artikel
19 Faster access to Cancer Drugs Fund Tanday, Sanjay
2012
13 6 p. e234-
1 p.
artikel
20 Fertility drugs and childhood leukaemia: is there a link? Burki, Talha Khan
2012
13 6 p. e235-
1 p.
artikel
21 Finally, a substantial role for radiotherapy in melanoma Macklis, Roger
2012
13 6 p. 561-562
2 p.
artikel
22 Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study Ahmed, Hashim U
2012
13 6 p. 622-632
11 p.
artikel
23 Global burden of cancers attributable to infections in 2008: a review and synthetic analysis de Martel, Catherine
2012
13 6 p. 607-615
9 p.
artikel
24 Global burden of infection-related cancer revisited Danaei, Goodarz
2012
13 6 p. 564-565
2 p.
artikel
25 Helping GPs to diagnose cancer earlier Senior, Kathryn
2012
13 6 p. e232-
1 p.
artikel
26 Home from Home Burki, Talha Khan
2012
13 6 p. 576-
1 p.
artikel
27 HPV vaccine dropoff fear Wilkinson, Emma
2012
13 6 p. e237-
1 p.
artikel
28 Lenalidomide maintenance for multiple myeloma Brower, Vicki
2012
13 6 p. e238-
1 p.
artikel
29 Low-dose radioiodine ablation for thyroid cancer Bennet, Neil
2012
13 6 p. e237-
1 p.
artikel
30 Lynch syndrome: new tales from the crypt Boland, C Richard
2012
13 6 p. 562-564
3 p.
artikel
31 microRNAs in cancer management Kong, Yi W
2012
13 6 p. e249-e258
nvt p.
artikel
32 mTOR inhibition in hormone-resistant breast cancer Sharma, Sharan Prakash
2012
13 6 p. e239-
1 p.
artikel
33 New treatment options in advanced bladder cancer Brower, Vicki
2012
13 6 p. e233-
1 p.
artikel
34 NICE guidance on cabazitaxel for hormone-refractory metastatic prostate cancer previously treated with a docetaxel-containing regimen Jilani, Anwar
2012
13 6 p. 573-574
2 p.
artikel
35 Optimising radiation treatment decisions for patients who receive neoadjuvant chemotherapy and mastectomy Hoffman, Karen E
2012
13 6 p. e270-e276
nvt p.
artikel
36 Personalised medicine in nasopharyngeal cancer Toh, Han Chong
2012
13 6 p. 568-569
2 p.
artikel
37 Polyglutamine diseases and the risk of cancer Pouladi, Mahmoud A
2012
13 6 p. 569-571
3 p.
artikel
38 Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial Fujita, Shin
2012
13 6 p. 616-621
6 p.
artikel
39 Prevalence of mismatch repair-deficient crypt foci in Lynch syndrome: a pathological study Kloor, Matthias
2012
13 6 p. 598-606
9 p.
artikel
40 Priorities for cancer prevention Page, Jamie
2012
13 6 p. e230-
1 p.
artikel
41 Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis Liu, Na
2012
13 6 p. 633-641
9 p.
artikel
42 Prostate cancer treatment unblinded Tsivian, Matvey
2012
13 6 p. 567-568
2 p.
artikel
43 Second-line everolimus treatment in advanced renal-cell cancer Brower, Vicki
2012
13 6 p. e235-
1 p.
artikel
44 Short-term androgen deprivation therapy for patients with intermediate-risk prostate cancer undergoing dose-escalated radiotherapy: the standard of care? Zumsteg, Zachary S
2012
13 6 p. e259-e269
nvt p.
artikel
45 Voices from the front: June Mastrianni, David M
2012
13 6 p. 578-
1 p.
artikel
                             45 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland